Founded in 2016, our company is a globally innovative medical technology enterprise specializing in continuous glucose monitoring (CGM) product technology and blood glucose management. Our headquarters and R&D center are located in Suzhou, with production bases established in both Suzhou and Nantong. Our company boasts a team of technology professionals from renowned institutions, possessing significant technical advantages in semipermeable membrane biomaterials, intelligent algorithm systems, and enzyme-catalyzed sensors. We have obtained approval for marketing from the National Medical Products Administration (NMPA) and the European Union (CE) certificate.

We are committed to serving individuals with diabetes and healthcare professionals, and through continuous technological innovation, we aim to become a driving force in transforming diabetes care and management, enabling people to enjoy a better life.